Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
  • Donate
Select Page
Auto Draft

Mayo Clinic Researchers ID Potential Gene Marker for Treating Pancreatic Cancer

by admin | Dec 31, 2022 | News & Opinions

By Joe Dangor – Mayo Clinic ROCHESTER, Minn. — Researchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancreatic ductal adenocarcinoma (PDAC). The researcher’s findings are...
CRISPR cancer trial success paves the way for personalized treatments

CRISPR cancer trial success paves the way for personalized treatments

by admin | Dec 30, 2022 | News & Opinions

By Heidi Ledford – Nature ‘Most complicated therapy ever’ tailors bespoke, genome-edited immune cells to attack tumours. A small clinical trial has shown that researchers can use CRISPR gene editing to alter immune cells so that they will recognize mutated...
Monoclonal antibodies preserve stem cells in mouse brains, bring promise for future studies

Monoclonal antibodies preserve stem cells in mouse brains, bring promise for future studies

by admin | Dec 29, 2022 | News & Opinions

By Noah Fromson – University of Michigan Health Image caption: Human neural stem cell transplants (green) survive and migrate throughout the mouse brain (blue) when given a novel monoclonal antibody treatment. Michigan Medicine Using antibodies instead of...
Addressing the challenges of chimeric antigen receptor-T cell therapy

Addressing the challenges of chimeric antigen receptor-T cell therapy

by admin | Dec 29, 2022 | News & Opinions

By Susan Murphy – Mayo Clinic Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) — a type of immunotherapy that reprograms a patient’s T cells to recognize and destroy cancer cells — has revolutionized the treatment of blood cancers. While the...
Cell and Gene Therapy: Current Challenges and the Benefits of Automation

Cell and Gene Therapy: Current Challenges and the Benefits of Automation

by admin | Dec 28, 2022 | News & Opinions

By Anna MacDonald and Sarah Whelan – Technology Networks Cell and gene therapy is a field of personalized medicine, driving the innovation of medicine and revolutionizing the way we treat disease. Gene therapies use DNA or other genetic material to edit a...
Page 148 of 167« First«147148149»Last »

Recent Posts

  • UC Irvine receives $12 million to test novel stem cell therapy for Huntington’s disease
  • Novel surgical approach for retinal gene therapy shows promise
  • The Best Biomarkers For Longevity, According To Experts
  • Regeneron’s experimental therapy combo effective in untreated cancer patients
  • The quest to slow aging leads scientists into the powerhouse of cells
Tweets about @WSCSummit